Search research articles
Contact Us
Filters
Showing results (291-300 of 343) with videos related to
Page
of 35
Sort By:
Infection
|
November 26, 2024
Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study
Nofar Hezkelo Attias, Tal Schlaeffer-Yosef, Itay Zahavi, et al.
Open Forum Infectious Diseases
|
May 26, 2022
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection
Jessica Howard-Anderson, Weixiao Dai, Dafna Yahav, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2018
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection
Sarah B Doernberg, Thuy Tien Tram Tran, Steven Y C Tong, et al.
JAMA
|
April 18, 2026
Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical Trial
Ritu Banerjee, Lauren Komarow, Yixuan Li, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 13, 2021
In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infections
Amir Nutman, Elizabeth Temkin, Jonathan Lellouche, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 7, 2020
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
Amir Nutman, Jonathan Lellouche, Elizabeth Temkin, et al.
Antimicrobial Agents and Chemotherapy
|
March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"
Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps
Valeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
Antimicrobial Agents and Chemotherapy
|
January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed
Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Pharmacotherapy
|
February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Page
of 35
Search research articles
Search
Showing results (291-300 of 343) with videos related to
Sort By:
Page
of 35
Infection
|
November 26, 2024
Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort study
Nofar Hezkelo Attias, Tal Schlaeffer-Yosef, Itay Zahavi, et al.
Open Forum Infectious Diseases
|
May 26, 2022
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection
Jessica Howard-Anderson, Weixiao Dai, Dafna Yahav, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2018
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection
Sarah B Doernberg, Thuy Tien Tram Tran, Steven Y C Tong, et al.
JAMA
|
April 18, 2026
Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical Trial
Ritu Banerjee, Lauren Komarow, Yixuan Li, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 13, 2021
In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infections
Amir Nutman, Elizabeth Temkin, Jonathan Lellouche, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 7, 2020
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
Amir Nutman, Jonathan Lellouche, Elizabeth Temkin, et al.
Antimicrobial Agents and Chemotherapy
|
March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"
Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps
Valeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
Antimicrobial Agents and Chemotherapy
|
January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed
Mark S Butler, Valeria Gigante, Hatim Sati, et al.
Pharmacotherapy
|
February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Page
of 35